Discover

IRMD
IRadimed Corporation
94.97
1 x 78.80
1 x 99.56
bid
ask
-
2.06
2.12%
04:00 PM
Ytd-2.37%
1y69.02%
94.62
day range
97.10
55.11
52 week range
107.90
Open96.59Prev Close97.03Low94.62High97.10Mkt Cap1.21B
Vol126.07KAvg Vol137.17KEPS1.99P/E47.72Forward P/E41.15
Beta0.90Short Ratio4.59Inst. Own61.25%Dividend0.80Div Yield0.82
Ex Div Date05-15Earning07-3050-d Avg93.09200-d Avg92.651yr Est118.00
Earning
DateForEstimateReportedSurprisesurprise %
2026-07-302026-060.44N/AN/AN/A
2026-05-012026-030.420.490.0716.67%
2026-02-102025-120.490.540.0510.20%
2025-11-032025-090.480.47-0.01-2.08%
2025-08-012025-060.450.490.048.89%
2025-05-052025-030.430.42-0.01-2.33%
Upgrade / Downgrade
DateFirmActionFromTo
2026-04-02Freedom BrokerUpgradeBuy
2025-02-14Roth MKMUpgradeBuyBuy
2024-08-02Roth MKMUpgradeBuyBuy
2021-08-02Roth CapitalUpgradeBuy
2017-07-31Roth CapitalUpgradeNeutralBuy
2016-10-05Roth CapitalDowngradeBuyNeutral
Profile
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
Insider Holder
DateNameRelationQuantityDescription
2026-02-12ALLEN MONTY KDirector21.00KSale
2025-12-10CHIPRIN JEFFOfficer687.00Conversion of Exercise of derivative security
2026-06-17GLENN JOHN FChief Financial Officer11.94KConversion of Exercise of derivative security
2025-12-10HAWKINS JAMES BDirector29.65KConversion of Exercise of derivative security
2026-06-03SCHAREN-GUIVEL HILDA FREDERIQUEDirector5.60KSale
2026-05-31SUSI ROGER EChief Executive Officer0.00Sale
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30BlackRock Inc967.79K0.007.57%
2025-12-30Vanguard Group Inc560.05K0.004.38%
2026-03-30Renaissance Technologies Corp440.71K0.003.45%
2026-03-30Copeland Capital Management, LLC359.33K0.002.81%
2026-03-30Vanguard Capital Management, LLC358.62K0.002.81%
2026-03-30Kayne Anderson Rudnick Investment Management LLC349.32K0.002.73%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Vanguard Total Stock Mkt Idx Inv264.37K0.002.07%
2026-06-29iShares Russell 2000 ETF218.10K0.001.71%
2026-03-30Virtus KAR Small-Cap Growth I139.50K0.001.09%
2026-06-29T. Rowe Price Small-Cap Value116.90K0.000.91%
2026-06-29Ranger Micro Cap98.35K0.000.77%
2026-03-30JNL Multi-Manager Small Cap Growth A95.68K0.000.75%
Dividend
DividendDate
0.22026-05-15
0.22026-02-23
0.52025-12-17
0.172025-11-14
0.172025-08-18
0.172025-05-20